Physiomics (LON:PYC) Stock Price Down 3.7% – What’s Next?

Physiomics Plc (LON:PYC) shares dropped 3.7% during trading on Tuesday . The company traded as low as GBX 0.65 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 251,407 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 1,594,712 shares. The stock had previously closed at GBX 0.68 ($0.01).

Physiomics Price Performance

The business has a fifty day moving average of GBX 0.67 and a 200 day moving average of GBX 0.82. The stock has a market cap of £1.32 million, a PE ratio of -13.83 and a beta of 1.69.

Insiders Place Their Bets

In other news, insider Peter Sargent bought 459,090 shares of Physiomics stock in a transaction on Thursday, November 7th. The shares were bought at an average price of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,817.16). 4.18% of the stock is currently owned by company insiders.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.